🇺🇸 FDA
Pipeline program

low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated

PRO-EV71/CA16-1001

Phase 2 mab active

Quick answer

low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated for Hand, Foot and Mouth Disease is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Hand, Foot and Mouth Disease
Phase
Phase 2
Modality
mab
Status
active

Clinical trials